Mucinous cystadenoma of childhood
myoo-sin-us sis-tad-uh-NO-muh
Also known as: Pediatric mucinous cystadenoma, Juvenile mucinous cystadenoma
At a Glance
What is Mucinous cystadenoma of childhood?
Mucinous cystadenoma of childhood is a rare type of benign tumor that occurs in the ovaries of children and adolescents. It primarily affects the reproductive system but can also impact surrounding abdominal organs due to its size. The exact cause is unknown, but it is not usually inherited. Over time, the tumor can grow quite large, leading to abdominal pain or swelling. Early symptoms may include a noticeable abdominal mass or discomfort, while later symptoms can involve more severe pain or complications from pressure on other organs. Early diagnosis is important to prevent complications and ensure effective treatment. The condition can be stressful for families due to the need for medical intervention and potential surgery. Prognosis is generally good with surgical removal, as the tumor is benign. Daily life for affected individuals can return to normal after treatment, but regular follow-up is important to monitor for recurrence. The condition does not typically affect life expectancy. Support from healthcare providers and family can help manage the emotional and physical aspects of the condition.
Medical Definition
Mucinous cystadenoma is a benign epithelial tumor characterized by cystic structures lined with mucin-producing epithelial cells. Histologically, these tumors are composed of a single layer of columnar cells with abundant intracellular mucin. They are classified under the WHO classification of ovarian tumors as benign epithelial tumors. Epidemiologically, they are rare in children, with most cases reported in adolescents. The disease course involves slow growth, and while benign, the tumors can become very large and cause significant symptoms due to mass effect. Surgical excision is the treatment of choice, and prognosis is excellent with complete removal.
Mucinous cystadenoma of childhood Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Abdominal pain manifests as a dull or sharp ache in the lower abdomen, often worsening with movement. It is caused by the pressure exerted by the growing cyst on surrounding tissues and organs. Over time, the pain may become more frequent and severe as the cyst enlarges. This symptom can significantly affect daily activities, limiting physical movement and causing discomfort; pain management and surgical intervention can alleviate symptoms.
Abdominal distension presents as a noticeable increase in abdominal girth, often accompanied by a feeling of fullness. This occurs due to the accumulation of fluid or the mass effect of the cyst itself. As the cyst grows, distension becomes more pronounced, potentially causing discomfort and difficulty in fitting clothes. Addressing this symptom involves monitoring the cyst's size and considering surgical removal to relieve pressure.
A palpable abdominal mass is detected as a firm, localized swelling in the abdomen during physical examination. It results from the physical presence of the cystadenoma within the abdominal cavity. The mass may increase in size over time, becoming more prominent and easier to detect. This symptom can cause anxiety and discomfort, prompting further diagnostic imaging and potential surgical intervention.
Common
Nausea is an unsettling sensation in the stomach that often precedes vomiting. It is caused by the pressure of the cyst on the stomach and intestines, disrupting normal digestive processes. Over time, nausea may become more persistent, especially after meals or physical activity. Managing this symptom involves dietary modifications and, if necessary, medical treatment to control nausea.
Vomiting involves the forceful expulsion of stomach contents through the mouth. It occurs due to irritation and pressure on the gastrointestinal tract by the cyst. As the condition progresses, vomiting episodes may increase in frequency, leading to dehydration and nutritional deficiencies. Treatment focuses on managing fluid and electrolyte balance and addressing the underlying cause.
Weight loss is characterized by a reduction in body weight, often noticeable over weeks or months. It can result from decreased appetite and nutrient absorption due to gastrointestinal discomfort caused by the cyst. If untreated, weight loss may become significant, affecting overall health and energy levels. Nutritional support and addressing the cyst's impact on digestion can help manage this symptom.
Less Common
Urinary frequency is the need to urinate more often than usual, sometimes accompanied by urgency. This symptom arises when the cyst exerts pressure on the bladder, reducing its capacity. Over time, urinary frequency can disrupt daily activities and sleep patterns. Management includes monitoring fluid intake and considering surgical options to relieve bladder pressure.
Constipation is characterized by infrequent or difficult bowel movements, often with hard stools. It is caused by the cyst pressing against the intestines, hindering normal bowel function. As the cyst grows, constipation may worsen, leading to discomfort and bloating. Dietary adjustments, increased fluid intake, and medical interventions can help alleviate this symptom.
What Causes Mucinous cystadenoma of childhood?
Mucinous cystadenoma of childhood is often associated with mutations in the STK11 gene, located on chromosome 19p13.3. The STK11 gene encodes the serine/threonine kinase 11 protein, which is involved in regulating cell polarity, metabolism, and apoptosis. Mutations in STK11 can lead to loss of kinase activity, disrupting cell cycle control and promoting abnormal cell proliferation. This disruption results in aberrant signaling pathways, such as the mTOR pathway, leading to uncontrolled cell growth and cyst formation. The accumulation of mucinous material within the cysts causes pressure effects on surrounding tissues, potentially leading to inflammation. Neuroinflammation and immune responses are triggered as the body attempts to manage the abnormal growth, which can exacerbate tissue damage. The degeneration of surrounding structures, such as ovarian stroma, occurs as the cysts expand and compress adjacent tissues. Symptoms often appear as abdominal pain or palpable masses due to the physical presence of the cysts. The pattern of symptom presentation is influenced by the size and location of the cysts, as well as the degree of local inflammation. Disease severity varies between patients due to differences in mutation type, genetic background, and environmental factors. Some patients may experience rapid cyst growth, while others have a more indolent course. The presence of additional genetic mutations or polymorphisms can further modulate disease progression and symptomatology. Understanding the molecular and cellular mechanisms underlying mucinous cystadenoma is crucial for developing targeted therapies. Current research focuses on identifying biomarkers for early detection and potential therapeutic targets to inhibit cyst growth.
How is Mucinous cystadenoma of childhood Diagnosed?
Typical age of diagnosis: Mucinous cystadenoma in childhood is typically diagnosed in premenarchal girls, often presenting as an abdominal mass. Diagnosis usually occurs when the child presents with abdominal distension or pain, prompting further investigation. The condition can be detected incidentally during imaging for unrelated issues. Early diagnosis is crucial for effective management and to prevent complications.
Clinicians look for symptoms such as abdominal pain, distension, or a palpable mass. A detailed history including onset of symptoms and any familial predispositions is crucial. Physical examination may reveal an abdominal mass or tenderness. This step helps determine the need for further diagnostic imaging.
Ultrasound is the primary imaging modality used to evaluate suspected abdominal masses. It typically shows a cystic mass with possible septations or solid components. These findings help confirm the diagnosis of mucinous cystadenoma and exclude other differential diagnoses like teratomas or simple cysts. CT or MRI may be used for further characterization and surgical planning.
Blood tests may include tumor markers such as CA-125, although they are not specific for mucinous cystadenoma. Elevated markers can suggest malignancy, prompting more aggressive investigation. Normal results can help reassure and guide towards a benign diagnosis. These tests assist in planning the extent of surgical intervention.
Genetic testing may involve sequencing genes like STK11 or PTEN if syndromic associations are suspected. Mutations in these genes can indicate conditions like Peutz-Jeghers syndrome or Cowden syndrome. Confirming a genetic diagnosis can guide management and inform family counseling. It also helps assess the risk of recurrence in siblings or future offspring.
Mucinous cystadenoma of childhood Treatment Options
Hormonal therapy may be considered to manage symptoms or prevent recurrence. These drugs work by regulating hormonal levels that could influence cyst growth. Commonly used drugs include oral contraceptives or GnRH analogs. Clinical evidence for efficacy is limited, and they are primarily used adjunctively. Side effects can include weight gain, mood changes, and thromboembolic events.
Physical therapy focuses on recovery and strengthening post-surgery. Techniques include abdominal exercises and breathing exercises to improve core stability and lung function. Sessions are typically conducted 2-3 times a week for several weeks. Measurable outcomes include improved mobility and reduced pain. Long-term benefits include enhanced physical function and quality of life.
Surgery is indicated for symptomatic cysts or when malignancy cannot be excluded. The procedure involves the removal of the cyst while preserving as much ovarian tissue as possible. Benefits include symptom relief and prevention of complications like torsion or rupture. Risks include infection, bleeding, and potential impact on fertility. Post-operative care involves pain management and monitoring for complications.
The care team includes pediatricians, surgeons, geneticists, and psychologists. Interventions focus on comprehensive management, including medical, surgical, and psychosocial aspects. Psychosocial support strategies involve counseling and support groups for the patient and family. Family education covers disease understanding, treatment options, and genetic implications. Long-term monitoring includes regular follow-ups to detect recurrence or complications early.
When to See a Doctor for Mucinous cystadenoma of childhood
- Severe abdominal pain — this could indicate a rupture or torsion of the cyst, which is a surgical emergency.
- Sudden onset of fever and vomiting — these symptoms may suggest an infection or complication requiring immediate medical attention.
- Rapid abdominal swelling — this could be a sign of internal bleeding or a rapidly growing mass, necessitating urgent evaluation.
- Persistent abdominal discomfort — this may indicate a growing cyst and should be evaluated by a healthcare provider.
- Irregular menstrual cycles — could suggest hormonal imbalances related to the cyst and warrants further investigation.
- Unexplained weight loss — may be associated with metabolic changes or malignancy, and should be assessed by a doctor.
- Mild bloating — monitor for changes in size or associated symptoms, and consult a doctor if it worsens.
- Occasional mild pelvic discomfort — keep track of frequency and intensity, and seek medical advice if it becomes persistent.
Mucinous cystadenoma of childhood — Frequently Asked Questions
Is this condition hereditary?
Mucinous cystadenoma of childhood is not typically considered hereditary. The probability of passing it to children is low as it usually occurs sporadically. De novo mutations are not commonly associated with this condition. Carrier status is not applicable as it is not a genetic disorder. Genetic counseling is generally not necessary unless there is a family history of related conditions.
What is the life expectancy for someone with this condition?
Life expectancy is generally normal if the condition is treated promptly. Prognosis is excellent when diagnosed early and managed appropriately. Mortality is rare and usually related to complications such as rupture or infection. Surgical removal of the cyst typically resolves the condition without long-term effects. Patients can expect a full recovery with timely intervention.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves imaging studies such as ultrasound or MRI to identify the cyst. The time from first symptoms to diagnosis can vary, often taking weeks to months. Pediatricians and pediatric surgeons are typically consulted. Delayed diagnosis may occur due to nonspecific symptoms or misattribution to other conditions. Confirmation is achieved through surgical exploration and histopathological examination of the cyst.
Are there any new treatments or clinical trials available?
Research is ongoing into less invasive surgical techniques and improved imaging modalities. Gene therapy is not applicable, but novel approaches in minimally invasive surgery are promising. Clinical trials can be found on ClinicalTrials.gov by searching for 'mucinous cystadenoma' and related terms. Patients should ask their doctor about eligibility for trials and potential benefits. New treatments are expected to improve recovery times and reduce complications.
How does this condition affect daily life and activities?
The condition can cause temporary limitations in mobility and self-care due to abdominal pain. School attendance may be affected during periods of discomfort or post-surgery recovery. Social and emotional challenges may arise from body image concerns or anxiety about health. Family burden includes managing medical appointments and supporting recovery. Supportive measures such as counseling and educational accommodations can be beneficial.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Mucinous cystadenoma: a rare abdominal mass in childhood.
Yazici M, Etensel B, Gürsoy H et al. · Eur J Pediatr Surg · 2002 · PMID: 12469261
- 2.Mucinous cystadenoma of ovary in a patient with juvenile polyposis due to 10q23 microdeletion: expansion of phenotype.
Babovic N, Simmons PS, Moir C et al. · Am J Med Genet A · 2010 · PMID: 20815035
- 3.Ovarian mucinous cystadenoma with extended calcification in an 11-year-old girl: case report and review of the literature.
Grapsa D, Kairi-Vassilatou E, Hasiakos D et al. · Clin Exp Obstet Gynecol · 2006 · PMID: 17089585
- 4.Unique features and insights from mucinous tumors of ovary in childhood: clinicopathological study of 15 cases including four premenarchal cases.
Fan R · Fetal Pediatr Pathol · 2014 · PMID: 24575832
- 5.[Mixed germ cell tumours of the ovary in childhood and adolescence].
Zuntová A, Sumerauer D, Teslík L et al. · Cesk Patol · 2004 · PMID: 15493415
- 6.A 9-kg ovarian mucinous cystadenoma in a 14-year-old premenarchal girl.
Biçer S, Erkul Z, Demiryilmaz I et al. · Am J Case Rep · 2014 · PMID: 25082433
- 7.Mucinous cystadenoma arising in a completely isolated infected ileal duplication cyst.
Collaud S, Bayerl C, Wille G et al. · S Afr J Surg · 2012 · PMID: 22622103
- 8.[Contribution to the knowledge of tumors of the ovary in childhood and puberty].
Mitolo G, Bellone F · Minerva Ginecol · 1966 · PMID: 4297573
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-29